From Name:
From Email:
To Name:
To Email:

Optional Message:

Ribociclib offers 'paradigm shift' in advanced breast cancer

from Medscape

The investigational drug ribociclib (formerly LEE011, Novartis) added to letrozole in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer showed significant improvement in progression-free survival (PFS) compared with letrozole alone, new results show. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063